[HTML][HTML] The role of CD133 in cancer: a concise review
PM Glumac, AM LeBeau - Clinical and translational medicine, 2018 - Springer
Despite the abundant ongoing research efforts, cancer remains one of the most challenging
diseases to treat globally. Due to the heterogenous nature of cancer, one of the major …
diseases to treat globally. Due to the heterogenous nature of cancer, one of the major …
Caspase‐8: A key protein of cross‐talk signal way in “PANoptosis” in cancer
M Jiang, L Qi, L Li, Y Wu, D Song… - International journal of …, 2021 - Wiley Online Library
Cysteinyl aspartate specific proteinase (Caspase)‐8 has long been considered a promoter
of apoptosis and part of the mechanism by which cytotoxic drugs kill cancer cells. With the …
of apoptosis and part of the mechanism by which cytotoxic drugs kill cancer cells. With the …
Microneedle-mediated transdermal drug delivery for treating diverse skin diseases
D Yang, M Chen, Y Sun, Y Jin, C Lu, X Pan, G Quan… - Acta Biomaterialia, 2021 - Elsevier
Transdermal drug delivery is an attractive route for dermatological disease therapy because
it can directly target the lesion site on the skin, reduce adverse reactions associated with …
it can directly target the lesion site on the skin, reduce adverse reactions associated with …
[HTML][HTML] Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells
H Rezayatmand, M Razmkhah… - Stem cell research & …, 2022 - Springer
Drug resistance is the main culprit of failure in cancer therapy that may lead to cancer
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …
Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistance
SM Elgendy, SK Alyammahi, DW Alhamad… - Critical Reviews in …, 2020 - Elsevier
Resistance to chemotherapeutic agents remains a major challenge in the fierce battle
against cancer. Cancer stem cells (CSCs) are a small population of cells in tumors that …
against cancer. Cancer stem cells (CSCs) are a small population of cells in tumors that …
Bcl-2 antiapoptotic family proteins and chemoresistance in cancer
Cancer is a daunting global problem confronting the world's population. The most frequent
therapeutic approaches include surgery, chemotherapy, radiotherapy, and more recently …
therapeutic approaches include surgery, chemotherapy, radiotherapy, and more recently …
DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG
Platinum based drugs alone or in combination with 5FU and docetaxel are common regimen
chemotherapeutics for the treatment of advanced OSCC. Chemoresistance is one of the …
chemotherapeutics for the treatment of advanced OSCC. Chemoresistance is one of the …
[HTML][HTML] Chemopreventive and anticancer activity of flavonoids and its possibility for clinical use by combining with conventional chemotherapeutic agents
Cancer is a diverse class of diseases characterized by uncontrolled cell growth with the
potential to invade and spread to other parts of the body, and continues to be one of the …
potential to invade and spread to other parts of the body, and continues to be one of the …
[HTML][HTML] Cancer stem cells and their possible implications in cervical cancer: a short review
R Di Fiore, S Suleiman, R Drago-Ferrante… - International journal of …, 2022 - mdpi.com
Cervical cancer (CC) is the fourth most common type of gynecological malignancy affecting
females worldwide. Most CC cases are linked to infection with high-risk human …
females worldwide. Most CC cases are linked to infection with high-risk human …
[HTML][HTML] Overview of cancer stem cells and stemness for community oncologists
Advances in cancer research in the past have led to an evolving understanding of cancer
pathogenesis and the development of novel drugs that significantly improve patient …
pathogenesis and the development of novel drugs that significantly improve patient …